Inventors with similar research interests:
Location History:
- Tokyo, JA (1976)
- Toshima, JP (1984 - 1993)
- Shinjuku, JP (1992 - 1996)
- Tokyo, JP (1980 - 1997)
Company Filing History:
41 out of 229 
11 out of 15 
4 out of 328 
Years Active: 1976-1997
Areas of Expertise:
Title: The Innovative Contributions of Ei Mochida: A Pioneer in Biotechnology
Introduction: Ei Mochida, based in Tokyo, Japan, is a distinguished inventor renowned for his significant contributions to the fields of biotechnology and pharmaceuticals. With an impressive portfolio of 52 patents, his innovative works focus primarily on recombinant DNA technology and measurement apparatuses, providing solutions that advance medical science.
Latest Patents: Mochida's recent patents illustrate his commitment to addressing critical health challenges. One particularly notable invention involves recombinant DNA vectors, which are instrumental in producing polypeptides with thrombin binding ability, anticoagulant activity, and thrombolytic activity. This application not only enhances the efficiency of polypeptide production through genetic recombination techniques but also promises effective treatment options for hypercoagulability-related diseases without the adverse effects typically associated with anticoagulant therapies.
Additionally, Mochida has developed a simplified measuring apparatus designed for qualitative and quantitative assessments of substances such as proteins and antibodies. This innovative device allows users to conduct tests using minimal samples without the need for a separation step, thereby streamlining the measurement process and making it accessible for wider use.
Career Highlights: Throughout his career, Ei Mochida has been affiliated with prominent companies such as Mochida Pharmaceutical Co., Ltd. and Mochida Seiyaku Kabushiki Kaisha. His work within these organizations has allowed him to make valuable contributions to healthcare, demonstrating his expertise and vision in the biotechnology sector.
Collaborations: Mochida has collaborated with other notable professionals in his field, including Haruo Ohnishi and Yasuo Suzuki. These partnerships have fostered a creative environment that mutually benefits the development of innovative solutions in biotechnology and pharmaceuticals.
Conclusion: Ei Mochida's remarkable contributions to the fields of biotechnology and pharmaceuticals exemplify the impact of innovative thinking on healthcare solutions. His extensive patent portfolio, encompassing cutting-edge inventions, positions him as a leading figure in medical advancements, promising to transform treatment methodologies and improve patient outcomes worldwide.